ORG Wealth Partners’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.07M Sell
24,100
-287
-1% -$61.7K 0.91% 16
2026
Q1
$5.3M Buy
24,387
+316
+1% +$70.1K 1.04% 14
2025
Q4
$5.51M Buy
24,071
+1,989
+9% +$453K 1.29% 12
2025
Q3
$5.12M Buy
22,082
+2,708
+14% +$551K 1.09% 13
2025
Q2
$3.69M Sell
19,374
-3,449
-15% -$641K 0.88% 16
2025
Q1
$4.71M Buy
22,823
+8,015
+54% +$1.56M 1.45% 12
2024
Q4
$2.63M Buy
14,808
+1,812
+14% +$333K 0.81% 15
2024
Q3
$2.57M Buy
+12,996
New +$2.43M 0.85% 15

Other funds holding ABBV

ORG Wealth Partners's ABBV Position: Q2 2026 in Review

ORG Wealth Partners reduced its AbbVie (ABBV) stake by 1.2% in Q2 2026, selling an estimated $61.7K and leaving 24,100 shares worth $6.07M. The position accounts for 0.91% of the portfolio, ranked #16.

ORG Wealth Partners first reported a position in ABBV in Q3 2024 and has held it in 8 quarters since. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • ORG Wealth Partners held 24,100 shares of AbbVie worth $6.07M as of Q2 2026.
  • ORG Wealth Partners sold 287 AbbVie shares in Q2 2026, an estimated $61.7K.
  • AbbVie made up 0.91% of ORG Wealth Partners's portfolio in Q2 2026, its #16 holding.
  • ORG Wealth Partners first reported a position in AbbVie in Q3 2024 and has held it in 8 quarters since.
  • 4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on ORG Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.